Calman Prussin, M.D., Joins Knopp Biosciences To Lead Clinical Development Of Dexpramipexole In Eosinophilic Asthma

PITTSBURGH--(BUSINESS WIRE)--Knopp Biosciences LLC announced today that Calman Prussin, M.D., formerly a senior investigator in eosinophil-associated inflammatory diseases at the National Institutes of Health and the outgoing chair of the American Board of Allergy and Immunology, has joined Knopp to head clinical and translational medicine in immunology.